The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure

Journal of Clinical Investigation

Volumn 107, Issue 3, 2001, Pages 325-331

  Stock, Jeffrey L ^a   Shinjo, Katsuhiro ^b   Burkhardt, John ^a   Roach, Marsha ^a   Taniguchi, Kana ^b   Ishikawa, Toshihisa ^b   Kim, Hyung Suk ^c   Flannery, Patrick J ^d   Coffman, Thomas M ^d   McNeish, John D ^a   Audoly, Laurent P ^a,d  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; ENZYME INHIBITOR; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTANOID RECEPTOR EP1;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BLOOD PRESSURE REGULATION; GENE ISOLATION; LIGAND BINDING; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; DBA MOUSE; FEMALE; GENETICS; HETEROZYGOTE; KIDNEY; LUNG; MALE; METABOLISM; MUTATION; PAIN THRESHOLD; PHYSIOLOGY; UTERUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD PRESSURE; ENZYME INHIBITORS; FEMALE; HETEROZYGOTE; KIDNEY; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MUTATION; PAIN THRESHOLD; PIROXICAM; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER; UTERUS;

EID: 0034746312     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6749     Document Type: Article

References (50)

1. Prostaglandins and inflammation
2. Pharmacological classification of prostanoid receptors: Properties, distribution, and structure of receptors and their subtypes
3. Prostanoid receptors: Structures, properties, and functions
4. The effects of nonsteroidal anti-inflammatory drugs on renal function: Experimental studies in animals
5. NSAIDs and increased in blood pressure. What is the clinical significance?
6. Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype
7. Production of chimeras between embryonic stem cells and embryos
8. The prostaglandin receptor EP4 triggers remodeling of the cardiovascular system at birth
9. A computerized system for measuring blood pressure in mice
10. Regulation of blood pressure by the type 1A receptor for angiotensin II
11. Angiotensin II responses in AT1a receptor-deficient mice: A role for AT1b receptors in blood pressure regulation
12. Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice
13. A new embryonic stem cell line from DBA/1lacJ mice allows genetic modification in a murine model of human inflammation
14. Failure of parturition in mice lacking the prostaglandin F receptor
15. Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor
16. Salt sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor
17. Prostagtandin synthase 2 gene disruption causes severe renal pathology in the mouse
18. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
19. The mouse genes for the EP1 prostanoid receptor and the PKN protein kinase overlap
20. 2
21. The role of arachidonic acid oxygenation products in pain and inflammation
22. The analgesic properties of piroxicam in animals in correlation with experimentally determined plasma levels
23. Prostaglandins as determinants of vascular reactivity
24. The relevance of prostaglandins in human hypertension
25. Nonsteroidal antiinflammatory drugs: Differences and similarities
26. Identification of specific EP receptors responsible for the hemodynamic effects of PGE2
27. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
28. Prostaglandin E(2) has antinociceptive effects through EP(1) receptor in the ventromedial hypothalamus in rats
29. In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs
30. Characterization of murine vasopressor and vasodepressor prostaglandin E2 receptors
31. The hemodynamic effects of prostaglandins in the rat. Evidence for important species variation in renovascular responses
32. Role of the renin-angiotensin system in prostaglandin E2-induced hypertension
33. A comparison of the vasodepressor effects of the cyclic effects of the cyclic endoperoxides PGG and PGH2 with those of PGD2 and PGE2 in hypertensive and normotensive rats
34. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes
35. Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney
36. Prostaglandin E2 inhibits renal collecting duct Na+ absorption by activating the EP1 receptor
37. Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney
38. Sexual dimorphism of sodium-sensitive renal-wrap hypertension
39. Ambulatory blood pressure in children followed for 3 years. Influence of sex and family history of hypertension
40. Role of gonads in hypertension-prone rats
41. A gender difference in the association between salt sensitivity and family history of hypertension
42. INTERSALT study: Results for 24 hour sodium and potassium, by age and sex
43. The effect of sodium intake on the blood pressure related to age and sex
44. Nociception in cyclooxygenase isozyme-deficient mice
45. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacininduced gastric ulceration
46. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo
47. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain
48. Pharmacological analysis of cyclooxygenase-1 in inflammation